🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Proteinuria

Diabetic Nephropathy in People With Diabetes. Prevalence and Predictive Factors NCT04916132n/a13 sites📍 Skejby📍 Copenhagen📍 Hillerød Herlev Hospital · Tests: Kidney Biopsy Effect of Montelukast on Kidney and Vascular Function in Type 1 Diabetes NCT05498116Phase 41 site📍 Aurora University of Colorado, Denver · Tests: Montelukast, Placebo Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN NCT05755386Phase 3131 sites📍 Los Angeles📍 Orange📍 San Francisco Novartis Pharmaceuticals · Tests: Placebo, iptacopan An Open-Label Phase 2 Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Podocyte Diseases NCT06664814Phase 21 site📍 Bethesda National Human Genome Research Institute (NHGRI) · Tests: ManNAc Improving Renal Complications in Adolescents With Type 2 Diabetes Through REsearch Cohort Study (National iCARE Study) NCT02818192n/a1 site📍 Winnipeg University of Manitoba Study of Ravulizumab in Pediatric Participants With Primary IgAN NCT07024563Phase 315 sites📍 Palo Alto📍 Aurora📍 Beijing Alexion Pharmaceuticals, Inc. · Tests: Ravulizumab Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Adolescents With Early Stages of Chronic Kidney Disease NCT07405216Phase 41 site📍 Aguascalientes Centenario Hospital Miguel Hidalgo · Tests: Dapagliflozin (10mg Tab), Placebo Hypertension in Children and Young People at Risk of Autosomal Dominant Polycystic Kidney Disease NCT07260071n/a1 site📍 London King's College London The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR Study NCT06059664Phase 21 site📍 Chapel Hill University of North Carolina, Chapel Hill · Tests: Finerenone Oral Tablet, Placebo A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria NCT05457283Phase 3151 sites📍 Phoenix📍 Los Angeles📍 Palo Alto Bayer · Tests: Finerenone (Kerendia, BAY94-8862) A Study of JADE101 in Participants With Immunoglobulin A Nephropathy NCT07541287Phase 222 sites📍 Chula Vista📍 Arvada📍 Denver Jade Biosciences, Inc. · Tests: JADE101 Role of Coenzyme Q10 in Chronic Kidney Disease NCT05942027Phase 41 site📍 Tanta Tanta University · Tests: Placebo, Co-Enzyme Q10 Proteinuria in Pre and Post Transplant NCT01094327n/a1 site📍 Miami University of Miami Study of WAL0921 in Patients With Glomerular Kidney Diseases NCT06466135Phase 250 sites📍 Los Angeles📍 Denver📍 Tamarac Walden Biosciences · Tests: WAL0921, Placebo Empagliflozin Treatment in Kidney Transplant Recipients NCT06013865Phase 45 sites📍 Hines📍 Iowa City📍 Omaha VA Office of Research and Development · Tests: Empagliflozin A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS) NCT07268638Phase 230 sites📍 Chula Vista📍 Garden Grove📍 Los Angeles Akebia Therapeutics · Tests: Praliciguat (Part A), Placebo (Part A), Praliciguat (Part B) Nefecon and Ambrisentan in IgA Nephropathy NCT07030894Phase 41 site📍 Changchun The First Hospital of Jilin University · Tests: "Nefecon®","Ambrisentan" Sparsentan for the Treatment of VEGF Signaling Pathway Inhibitor-Associated Proteinuria NCT07224776Phase 11 site📍 Boston Brigham and Women's Hospital · Tests: sparsentan, No sparsentan ACE Reno, Pico Cell Matrix and Its Effect on eGFR in Chronic Kidney Diseases NCT07187713Phase 41 site📍 Giza Ace Cells Lab Limited · Tests: ACE Reno A Study to Assess the Effects of Zigakibart on IgA Nephropathy. NCT07146906Phase 230 sites📍 San Francisco📍 Denver📍 Acworth Novartis Pharmaceuticals · Tests: zigakibart Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE) NCT04752293n/a1 site📍 Winston-Salem Wake Forest University Health Sciences Urinary Vitamin C Loss in Diabetic Subjects NCT00071526n/a1 site📍 Bethesda National Institute of Diabetes and Digestive and Kidney Dis… The International PNH Interest Group PNH Registry NCT06524726n/a1 site📍 Altamonte Springs International PNH Interest Group Role of Vitamin K2 in Chronic Kidney Disease NCT05942053Phase 41 site📍 Tanta Tanta University · Tests: Placebo, Vitamin K 2 Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin NCT07175051Phase 21 site📍 Chicago University of Illinois Chicago · Tests: Empagliflozin (oral) A Study to Evaluate the Effect of ARGX-121 on the Change in Proteinuria in Adult Participants With IgAN NCT07773727Phase 211 sites📍 Valencia📍 Miami📍 Miami argenx · Tests: ARGX-121, Placebo Algae Effects in Markers of Cardiovascular Risk and Gut Microbiome NCT07173062NA1 site📍 Porto Universidade do Porto · Tests: Spirulina Arthrospira platensis (microalgae), Gelidium corneum, Placebo Study of BHV-1400 in IgA Nephropathy NCT07054684Phase 115 sites📍 Farmington📍 Miami Lakes📍 Miami Lakes Biohaven Therapeutics Ltd. · Tests: BHV-1400 A Study of SC0062 Capsule for the Treatment of IgA Nephropathy with Proteinuria NCT06819826Phase 31 site📍 Guangzhou Biocity Biopharmaceutics Co., Ltd. · Tests: SC0062 strength 10mg, Placebo matched to SC0062 Therapeutic Effect of Hydroxychloroquine on Immunoglobulin A (IgA) Nephropathy Course QUIgAN Study NCT06350630Phase 28 sites📍 Clermont-Ferrand📍 Lyon📍 Marseille Centre Hospitalier Universitaire de Saint Etienne · Tests: Hydroxychloroquine Oral Tablet, Placebo oral tablet
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy